| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5634945 | World Neurosurgery | 2017 | 21 Pages |
Abstract
In patients with glioma, the use of 5-ALA is known to be associated with increased extent of resection and survival benefit. Our data and retrospective analysis of a larger patient cohort suggest that the use of 5-ALA in PCNSL should be included in a surgical approach, if this is reconsidered for select patients within a clinical study. In addition, even photodynamic therapy in combination with 5-ALA might be studied.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Georg Evers, Marcel Kamp, Nils Warneke, Wolfgang Berdel, Michael Sabel, Walter Stummer, Christian Ewelt,